Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Molecular Bases of Response to Copper Treatment in Menkes Disease, Related Phenotypes, and Unexplained Copper Deficiency

Trial Profile

Molecular Bases of Response to Copper Treatment in Menkes Disease, Related Phenotypes, and Unexplained Copper Deficiency

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 06 Dec 2018

At a glance

  • Drugs Copper histidine (Primary)
  • Indications Menkes kinky hair syndrome
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Nov 2018 Planned End Date changed from 31 Dec 2021 to 30 Sep 2021.
    • 28 Nov 2018 Planned primary completion date changed from 21 Dec 2021 to 30 Sep 2021.
    • 02 Nov 2018 Planned primary completion date changed from 31 Dec 2019 to 21 Dec 2021.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top